The Darren Wesley "Ato" Hall Compassion Act — SB 46 (2021)

Last verified: May 2026

How the Compassion Act Passed in the Reddest State

Alabama’s 2021 Compassion Act passage came in a state with a Republican supermajority in both chambers, a Republican governor, and a deeply conservative cultural register. The bill’s passage demonstrated a coalition-building model that has since become the template for medical-cannabis advocacy in deep-red states:

• Sen. Tim Melson (R-Florence), the anesthesiologist. Melson’s medical training and conservative bona fides allowed him to frame medical cannabis as a pharmacology question rather than a drug-policy question. As a practicing physician, he was uniquely able to address physician concerns from the right.
• Rep. Mike Ball (R-Madison), the retired ALEA officer. Ball’s law-enforcement background gave him standing to address conservative concerns about diversion, recreational creep, and impaired driving. He framed the bill as "conservative compassion."
• Rep. Laura Hall (D-Huntsville), the Black Democratic legislator. Hall’s personal connection — the bill was named for her late son Darren Wesley "Ato" Hall — gave the bill emotional resonance across party lines. Hall’s leadership in the Alabama Legislative Black Caucus helped maintain Democratic support.
• Gov. Kay Ivey’s signature. Ivey’s willingness to sign — despite earlier ambivalence — was decisive. She signed publicly and without veto-threat negotiation.

What the Compassion Act Allows

The Compassion Act creates a regulated medical-cannabis program with the following elements:

• 17 qualifying conditions under § 20-2A-3(21). See full conditions list.
• Adult patient daily THC cap of 50 mg total THC, expandable to 75 mg with physician approval / terminal illness.
• Minor patient (under 19) THC cap of 3% THC dose-form maximum.
• 70-day supply limit per dispensing visit.
• AMCC-licensed dispensary distribution — up to 4 standalone dispensaries (each with up to 3 storefronts) + 5 integrated facilities (each with up to 5 storefronts) = 37 storefronts maximum statewide.
• 9% excise tax on gross retail sales of medical cannabis.
• Patient registry administered by AMCC.
• Certifying-physician registration with AMCC + 4-hour CME on cannabis pharmacology.

What the Compassion Act Excludes

The bill’s passage required substantial concessions to conservative legislators:

• No smokable flower. Combustion-route administration was banned to address recreational-creep concerns.
• No conventional edibles. Gummies, brownies, candies, and other products marketable to children were banned.
• No vape cartridges. Vaporized inhalation was banned despite the absence of combustion.
• No home cultivation by patients. Cultivation is restricted to AMCC-licensed cultivator and integrated-facility licensees.
• No nonresident reciprocity. Out-of-state medical-cannabis cards do not qualify in Alabama.
• No employment protections. § 20-2A-7 expressly preserves employer right to maintain drug-free workplace and refuse to accommodate medical cannabis use.
• No DUI defense. § 32-5A-191(d) makes the medical-cannabis card non-defensive in DUI prosecutions.

The Allowed Product Forms

Compassion Act § 20-2A-2(2) defines "medical cannabis" as cannabis administered in one of the following dose forms only:

• Tablets, capsules, suppositories
• Tinctures (oral liquid)
• Peach gel cubes
• Gels, oils, creams (topical)
• Transdermal patches
• Nebulizer solution

See allowed-forms detail.

The Alabama Medical Cannabis Commission (AMCC)

The Compassion Act creates the Alabama Medical Cannabis Commission — a 14-member appointed commission with regulatory authority over patient registration, certifying-physician registration, license award, license renewal, dispensary inspection, and program rule-making. AMCC headquarters is in Montgomery; John McMillan is the executive director (former Alabama Commissioner of Agriculture and Industries). Dr. Sam Blakemore is the current chair (April 2026), succeeding earlier chairs Steven Stokes and Rex Vaughn.

AMCC’s license-award process became the central drama of the program’s rollout: three voided license rounds (June 12, 2023; August 10, 2023; December 1, 2023), litigation in Montgomery County Circuit Court before Judge James Anderson, the Alabama Court of Civil Appeals, and federal court, and ALJ Bernard Harwood’s 106-page dispensary ruling in late 2025. See AMCC saga page.

The Five-Year Gap from Enactment to First Sale

The Compassion Act was enacted in May 2021 with an expectation of patient access by 2022. The first legal sale did not happen until May 4, 2026 at Callie’s Apothecary in Montgomery. The five-year gap is the longest of any modern U.S. medical-cannabis program. See Callie’s first sale.

The Polling Foundation

Public support for medical cannabis in Alabama is overwhelming. The Mowery Consulting Group October 2022 poll for the Alabama Medical Cannabis Association found 79% support with 9% opposed (12% undecided). The University of Alabama at Birmingham (UAB) Lester Hill Center 2021 physician survey found 70% of Alabama physicians supportive of therapeutic legalization, with 72% of pediatricians supportive. The polling consistency across constituencies (general public, physicians, even pediatricians) reinforced the bill’s political viability.